These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 2324883

  • 1. Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine).
    Dubois RS, Rodgerson DO, Hambidge KM.
    J Pediatr Gastroenterol Nutr; 1990 Jan; 10(1):77-81. PubMed ID: 2324883
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.
    Morita J, Yoshino M, Watari H, Yoshida I, Motohiro T, Yamashita F, Okano Y, Hashimoto T.
    Dev Pharmacol Ther; 1992 Jan; 19(1):6-9. PubMed ID: 1307347
    [Abstract] [Full Text] [Related]

  • 4. [A case of Wilson's disease recovering from severe brain damage--special reference to trientine and D-penicillamine therapy].
    Ishitsu T, Chikazawa S.
    No To Hattatsu; 1989 May; 21(3):294-6. PubMed ID: 2736129
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
    Haslam RH, Sass-Kortsak A, Stout W, Berg M.
    Dev Pharmacol Ther; 1980 May; 1(5):318-24. PubMed ID: 7438976
    [Abstract] [Full Text] [Related]

  • 6. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease.
    Scheinberg IH, Jaffe ME, Sternlieb I.
    N Engl J Med; 1987 Jul 23; 317(4):209-13. PubMed ID: 3600712
    [Abstract] [Full Text] [Related]

  • 7. Triethylene-tetramine (trien) therapy for Wilson's disease.
    Saito H, Watanabe K, Sahara M, Mochizuki R, Edo K, Ohyama Y.
    Tohoku J Exp Med; 1991 May 23; 164(1):29-35. PubMed ID: 1926144
    [Abstract] [Full Text] [Related]

  • 8. Wilson's disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents.
    Williams FJ, Walshe JM.
    Brain; 1981 Dec 23; 104(Pt 4):735-52. PubMed ID: 7326565
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Wilson's disease, an end to the search for new therapy?
    May PM, Jones DC, Williams DR.
    Lancet; 1982 May 15; 1(8281):1127. PubMed ID: 6122924
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of Wilson's disease: penicillamine or triene?
    Kiechl SG, Willeit J, Aichner F, Felber S.
    Acta Neurol Scand; 1992 Feb 15; 85(2):154-7. PubMed ID: 1574992
    [No Abstract] [Full Text] [Related]

  • 20. Trientine for Wilson's disease.
    Med Lett Drugs Ther; 1986 Jul 04; 28(717):67. PubMed ID: 3724656
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.